Fibroblast Activation Protein-related Diseases

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-03-11
Clinical Trial Update: Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases [Phase 1, Phase 2]
This clinical trial update reports ongoing Phase 1/2 studies evaluating the Ga-68-labeled NI-FAPI-04 PET/CT imaging agent for fibroblast act…